HK2 and prostate carcinoma: Since the expression of hK2 protein is higher in malignant prostatic tissue versus benign tissue it has been also considered as a prostate cancer (PCa) biomarker since levels of hK2 in serum from PCa patients are increased relative to individuals with BPH [9,10,11,12].